PROGRAM OVERVIEW
Charles Kilo, M.D., F.A.C.E., F.A.C.P., F.A.A.C.
Jerome Cohen, MD, FACC, FACP, FAHA
Stephen Crespin, MD, FACE, FAHA

Complications & Management of Obesity
Samuel Klein, MD

A Practical Approach to Diabetes Education & Initiation of Insulin Therapy
Eve Gilstrap, RN, MSN, FNP-BC & Patricia Knutsen, ACNS-BC, CDE

New Approach to Treat Metabolic Syndrome & Vascular Disease
Clay Semenkovich, MD

Impact of Diabetes on Cardiovascular Disease
Edward Geltman, MD

Current Management of Type 2 Diabetes & Stress the New Guidelines of 2012
Sam Dagogo-Jack, MD, MRCP, FRCP

Update – Hypertension and Cardiovascular Complications
Angela Brown, M.D.

Diabetic Eye Disease – Current Evaluation & Treatment
Mark Gilbert Grand, MD

Update - Thyroid Disease
Hossein Gharib, MD

Update – Diagnosis & Treatment of Lipids in the Diabetic Patient
Robert Heinig, MD

Insulin Resistance – Multifactorial Syndrome Responsible for Diabetes &
Vascular Disease
Ralph De Fronzo, MD

New Guidelines: A Case-Based Approach to Management of Diabetic Dyslipidemia & CHD Prevention  
Stephen Crespin, MD, FACE, FAHA

Update – Chronic Diabetic Renal Disease & Kidney Transplantation
Daniel Brennan, MD                                                        

Glucotoxicity & Lipotoxicity in Type 2 Diabetes
Harold Lebovitz, MD         

Evaluation of the Diabetic Foot – Risk Assessment & Treatment
Allen Mark Jacobs, DPM, FACFAS, FAPWCA, FASPS

Medical Changes & Governmental Compliance
John Irwin, JD, MD, FCLM

Detection of New Gene Expression Patterns in Islets Points to Pathogenesis of Type 1 Diabetes
Emil Unanue, MD

FACULTY QUESTIONS AND ANSWERS